Global Beta-Nicotinamide Mononucleotide (NMN) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 91

Published Date: 29 Jun 2023

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Beta-Nicotinamide Mononucleotide (NMN) market size was valued at USD 306.1 million in 2022 and is forecast to a readjusted size of USD 679.1 million by 2029 with a CAGR of 12.1% during review period.

Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

Global key players of beta-nicotinamide mononucleotide (NMN) include GeneHarbor, Mirailab Bioscience, EffePharm, Herbalmax and Genex Formulas. Asia-Pacific is the largest producer, holds a share over 60%, followed by North America and Europe. In terms of product type, content greater than or equal to 98% is the largest segment, with a share over 99%. And in terms of application, the largest segment is Health Care Products, with a share over 99%.

The Global Info Research report includes an overview of the development of the Beta-Nicotinamide Mononucleotide (NMN) industry chain, the market status of Health Care Products (Content Greater than or Equal to 98%, Content Less than 98%), Cosmetics (Content Greater than or Equal to 98%, Content Less than 98%), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Beta-Nicotinamide Mononucleotide (NMN).

Regionally, the report analyzes the Beta-Nicotinamide Mononucleotide (NMN) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Beta-Nicotinamide Mononucleotide (NMN) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Beta-Nicotinamide Mononucleotide (NMN) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Beta-Nicotinamide Mononucleotide (NMN) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kg), revenue generated, and market share of different by Type (e.g., Content Greater than or Equal to 98%, Content Less than 98%).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Beta-Nicotinamide Mononucleotide (NMN) market.

Regional Analysis: The report involves examining the Beta-Nicotinamide Mononucleotide (NMN) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Beta-Nicotinamide Mononucleotide (NMN) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Beta-Nicotinamide Mononucleotide (NMN):
Company Analysis: Report covers individual Beta-Nicotinamide Mononucleotide (NMN) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Beta-Nicotinamide Mononucleotide (NMN) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Health Care Products, Cosmetics).

Technology Analysis: Report covers specific technologies relevant to Beta-Nicotinamide Mononucleotide (NMN). It assesses the current state, advancements, and potential future developments in Beta-Nicotinamide Mononucleotide (NMN) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Beta-Nicotinamide Mononucleotide (NMN) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Beta-Nicotinamide Mononucleotide (NMN) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Content Greater than or Equal to 98%
Content Less than 98%

Market segment by Application
Health Care Products
Cosmetics
Others

Major players covered
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Beta-Nicotinamide Mononucleotide (NMN) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Beta-Nicotinamide Mononucleotide (NMN), with price, sales, revenue and global market share of Beta-Nicotinamide Mononucleotide (NMN) from 2018 to 2023.
Chapter 3, the Beta-Nicotinamide Mononucleotide (NMN) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Beta-Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Beta-Nicotinamide Mononucleotide (NMN) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Beta-Nicotinamide Mononucleotide (NMN).
Chapter 14 and 15, to describe Beta-Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Beta-Nicotinamide Mononucleotide (NMN)
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Content Greater than or Equal to 98%
        1.3.3 Content Less than 98%
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Health Care Products
        1.4.3 Cosmetics
        1.4.4 Others
    1.5 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size & Forecast
        1.5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (2018-2029)
        1.5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 GeneHarbor
        2.1.1 GeneHarbor Details
        2.1.2 GeneHarbor Major Business
        2.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 GeneHarbor Recent Developments/Updates
    2.2 Herbalmax
        2.2.1 Herbalmax Details
        2.2.2 Herbalmax Major Business
        2.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.2.4 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Herbalmax Recent Developments/Updates
    2.3 Genex Formulas
        2.3.1 Genex Formulas Details
        2.3.2 Genex Formulas Major Business
        2.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Genex Formulas Recent Developments/Updates
    2.4 Shinkowa Pharmaceutical
        2.4.1 Shinkowa Pharmaceutical Details
        2.4.2 Shinkowa Pharmaceutical Major Business
        2.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.4.4 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Shinkowa Pharmaceutical Recent Developments/Updates
    2.5 Maac10 Formulas
        2.5.1 Maac10 Formulas Details
        2.5.2 Maac10 Formulas Major Business
        2.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Maac10 Formulas Recent Developments/Updates
    2.6 EffePharm
        2.6.1 EffePharm Details
        2.6.2 EffePharm Major Business
        2.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.6.4 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 EffePharm Recent Developments/Updates
    2.7 Bontac
        2.7.1 Bontac Details
        2.7.2 Bontac Major Business
        2.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.7.4 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Bontac Recent Developments/Updates
    2.8 CELFULL
        2.8.1 CELFULL Details
        2.8.2 CELFULL Major Business
        2.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.8.4 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 CELFULL Recent Developments/Updates
    2.9 Kingdomway
        2.9.1 Kingdomway Details
        2.9.2 Kingdomway Major Business
        2.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product and Services
        2.9.4 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Kingdomway Recent Developments/Updates

3 Competitive Environment: Beta-Nicotinamide Mononucleotide (NMN) by Manufacturer
    3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2018-2023)
    3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Beta-Nicotinamide Mononucleotide (NMN) by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2022
        3.4.2 Top 6 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2022
    3.5 Beta-Nicotinamide Mononucleotide (NMN) Market: Overall Company Footprint Analysis
        3.5.1 Beta-Nicotinamide Mononucleotide (NMN) Market: Region Footprint
        3.5.2 Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
        3.5.3 Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
        4.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2029)
        4.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2029)
        4.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Region (2018-2029)
    4.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
    4.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
    4.4 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
    4.5 South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
    4.6 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
    5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2018-2029)
    5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
    6.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2018-2029)
    6.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2029)

7 North America
    7.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
    7.2 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
    7.3 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
        7.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
        7.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
    8.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
    8.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
        8.3.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
        8.3.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
        9.3.1 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
    10.2 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
    10.3 South America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
        10.3.1 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
        10.3.2 South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
        11.3.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers
    12.2 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints
    12.3 Beta-Nicotinamide Mononucleotide (NMN) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Beta-Nicotinamide Mononucleotide (NMN) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Beta-Nicotinamide Mononucleotide (NMN)
    13.3 Beta-Nicotinamide Mononucleotide (NMN) Production Process
    13.4 Beta-Nicotinamide Mononucleotide (NMN) Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Beta-Nicotinamide Mononucleotide (NMN) Typical Distributors
    14.3 Beta-Nicotinamide Mononucleotide (NMN) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. GeneHarbor Basic Information, Manufacturing Base and Competitors
    Table 4. GeneHarbor Major Business
    Table 5. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product and Services
    Table 6. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. GeneHarbor Recent Developments/Updates
    Table 8. Herbalmax Basic Information, Manufacturing Base and Competitors
    Table 9. Herbalmax Major Business
    Table 10. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product and Services
    Table 11. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Herbalmax Recent Developments/Updates
    Table 13. Genex Formulas Basic Information, Manufacturing Base and Competitors
    Table 14. Genex Formulas Major Business
    Table 15. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
    Table 16. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Genex Formulas Recent Developments/Updates
    Table 18. Shinkowa Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 19. Shinkowa Pharmaceutical Major Business
    Table 20. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Product and Services
    Table 21. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Shinkowa Pharmaceutical Recent Developments/Updates
    Table 23. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
    Table 24. Maac10 Formulas Major Business
    Table 25. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
    Table 26. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Maac10 Formulas Recent Developments/Updates
    Table 28. EffePharm Basic Information, Manufacturing Base and Competitors
    Table 29. EffePharm Major Business
    Table 30. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product and Services
    Table 31. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. EffePharm Recent Developments/Updates
    Table 33. Bontac Basic Information, Manufacturing Base and Competitors
    Table 34. Bontac Major Business
    Table 35. Bontac Beta-Nicotinamide Mononucleotide (NMN) Product and Services
    Table 36. Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Bontac Recent Developments/Updates
    Table 38. CELFULL Basic Information, Manufacturing Base and Competitors
    Table 39. CELFULL Major Business
    Table 40. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product and Services
    Table 41. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. CELFULL Recent Developments/Updates
    Table 43. Kingdomway Basic Information, Manufacturing Base and Competitors
    Table 44. Kingdomway Major Business
    Table 45. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product and Services
    Table 46. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Kingdomway Recent Developments/Updates
    Table 48. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2018-2023) & (Kg)
    Table 49. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 50. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2018-2023) & (US$/Kg)
    Table 51. Market Position of Manufacturers in Beta-Nicotinamide Mononucleotide (NMN), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 52. Head Office and Beta-Nicotinamide Mononucleotide (NMN) Production Site of Key Manufacturer
    Table 53. Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
    Table 54. Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
    Table 55. Beta-Nicotinamide Mononucleotide (NMN) New Market Entrants and Barriers to Market Entry
    Table 56. Beta-Nicotinamide Mononucleotide (NMN) Mergers, Acquisition, Agreements, and Collaborations
    Table 57. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2023) & (Kg)
    Table 58. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2024-2029) & (Kg)
    Table 59. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2023) & (USD Million)
    Table 60. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2024-2029) & (USD Million)
    Table 61. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Region (2018-2023) & (US$/Kg)
    Table 62. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Region (2024-2029) & (US$/Kg)
    Table 63. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
    Table 64. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
    Table 65. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2018-2023) & (USD Million)
    Table 66. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2024-2029) & (USD Million)
    Table 67. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Type (2018-2023) & (US$/Kg)
    Table 68. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Type (2024-2029) & (US$/Kg)
    Table 69. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
    Table 70. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
    Table 71. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2018-2023) & (USD Million)
    Table 72. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2024-2029) & (USD Million)
    Table 73. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2023) & (US$/Kg)
    Table 74. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Application (2024-2029) & (US$/Kg)
    Table 75. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
    Table 76. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
    Table 77. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
    Table 78. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
    Table 79. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2023) & (Kg)
    Table 80. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2024-2029) & (Kg)
    Table 81. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2023) & (USD Million)
    Table 82. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2024-2029) & (USD Million)
    Table 83. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
    Table 84. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
    Table 85. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
    Table 86. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
    Table 87. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2023) & (Kg)
    Table 88. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2024-2029) & (Kg)
    Table 89. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2023) & (USD Million)
    Table 90. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2024-2029) & (USD Million)
    Table 91. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
    Table 92. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
    Table 93. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
    Table 94. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
    Table 95. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2023) & (Kg)
    Table 96. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2024-2029) & (Kg)
    Table 97. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2023) & (USD Million)
    Table 98. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2024-2029) & (USD Million)
    Table 99. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
    Table 100. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
    Table 101. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
    Table 102. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
    Table 103. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2023) & (Kg)
    Table 104. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2024-2029) & (Kg)
    Table 105. South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2023) & (USD Million)
    Table 106. South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2024-2029) & (USD Million)
    Table 107. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
    Table 108. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
    Table 109. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
    Table 110. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
    Table 111. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2023) & (Kg)
    Table 112. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2024-2029) & (Kg)
    Table 113. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2023) & (USD Million)
    Table 114. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2024-2029) & (USD Million)
    Table 115. Beta-Nicotinamide Mononucleotide (NMN) Raw Material
    Table 116. Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN) Raw Materials
    Table 117. Beta-Nicotinamide Mononucleotide (NMN) Typical Distributors
    Table 118. Beta-Nicotinamide Mononucleotide (NMN) Typical Customers
List of Figures
    Figure 1. Beta-Nicotinamide Mononucleotide (NMN) Picture
    Figure 2. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Type in 2022
    Figure 4. Content Greater than or Equal to 98% Examples
    Figure 5. Content Less than 98% Examples
    Figure 6. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Application in 2022
    Figure 8. Health Care Products Examples
    Figure 9. Cosmetics Examples
    Figure 10. Others Examples
    Figure 11. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (2018-2029) & (Kg)
    Figure 14. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price (2018-2029) & (US$/Kg)
    Figure 15. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Beta-Nicotinamide Mononucleotide (NMN) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Type (2018-2029) & (US$/Kg)
    Figure 30. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2029) & (US$/Kg)
    Figure 33. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Beta-Nicotinamide Mononucleotide (NMN) Market Drivers
    Figure 74. Beta-Nicotinamide Mononucleotide (NMN) Market Restraints
    Figure 75. Beta-Nicotinamide Mononucleotide (NMN) Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide (NMN) in 2022
    Figure 78. Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide (NMN)
    Figure 79. Beta-Nicotinamide Mononucleotide (NMN) Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway

Related Reports

Global Beta-Nicotinamide Mononucleotide (NMN) Supply, Demand and Key Producers, 2023-2029

Global Beta-Nicotinamide Mononucleotide (NMN) Supply, Demand and Key Producers, 2023-2029

date 29 Jun 2023

date Chemical & Material

The global Beta-Nicotinamide Mononucleotide (NMN) market size is expected to reach $ 679.1 million by 2029, rising at a market growth of 12.1% CAGR during the forecast period (2023-2029).

Global Beta-Nicotinamide Mononucleotide (NMN) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Beta-Nicotinamide Mononucleotide (NMN) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 22 Apr 2024

date Chemical & Material

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

Global Beta-Nicotinamide Mononucleotide (NMN) Supply, Demand and Key Producers, 2024-2030

Global Beta-Nicotinamide Mononucleotide (NMN) Supply, Demand and Key Producers, 2024-2030

date 22 Apr 2024

date Chemical & Material

Product Tags

beta nicotinamide mononucleotide nmn

Beta-Nicotinamide Mononucleotide (NMN)

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>